Metropolitan Life Insurance Company (MetLife)’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,434	Closed	-$11.2K	–	201
2024 Q1	$11.2K	Hold	1,434	–	–	﹤0.01%	2092
2023 Q4	$7.29K	Hold	1,434	–	–	﹤0.01%	2256
2023 Q3	$8.49K	Hold	1,434	–	–	﹤0.01%	2281
2023 Q2	$10.6K	Buy	+1,434	New	+$10.6K	﹤0.01%	2269